Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

December 01, 2015 4:19 PM ET

Healthcare Providers and Services

Company Overview of Dana-Farber Cancer Institute, Inc.

Company Overview

Dana-Farber Cancer Institute, Inc. provides cancer treatment and research services for adults and children in the United States. It offers adult treatment and care services for blood, breast, cutaneous/skin, gastrointestinal, genitourinary, gynecological, head and neck, hematology, melanoma, neuro-oncology, sarcoma, and thoracic cancer; and cancer genetics and prevention services. The company also provides treatment and care for children with cancer, such as blood diseases, bone and soft tissue tumors, brain tumors, histiocytosis, Hodgkin lymphoma, kidney tumors, leukemia, neuroblastoma, non-Hodgkin lymphoma, and rare tumors program. In addition, it offers training in cancer treatment and re...

450 Brookline Avenue

Boston, MA 02215-5450

United States

Founded in 1947





Key Executives for Dana-Farber Cancer Institute, Inc.

Chief Executive Officer and President
Chief Financial Officer
Chief Operating Officer and Executive Vice President
Age: 64
Senior Vice President and General Counsel
Compensation as of Fiscal Year 2015.

Dana-Farber Cancer Institute, Inc. Key Developments

Dana-Farber Cancer Institute, Inc. Presents at BIO-Europe 2015, Nov-02-2015

Dana-Farber Cancer Institute, Inc. Presents at BIO-Europe 2015, Nov-02-2015 . Venue: Munich, Germany.

Dana-Farber Cancer Institute Appoints Michael Reney as Chief Financial Officer

Dana-Farber Cancer Institute has named Michael Reney its Chief Financial Officer (CFO), where he will be responsible for all financial operations including accounts payable, financial planning and reporting, payroll, capital asset management, tax and general and patient accounting. He will start later this fall. Reney has more than 25 years of experience working in the leading hospitals and health care systems in Boston, most recently serving as senior vice president and CFO at Brigham and Women's HealthCare.

Dana-Farber Cancer Institute, Inc. Presents at BioPharm America 2015, Sep-16-2015 10:00 AM

Dana-Farber Cancer Institute, Inc. Presents at BioPharm America 2015, Sep-16-2015 10:00 AM. Venue: Boston Marriott Copley Place, 110 Huntington Avenue, Boston, MA 02116, United States. Speakers: Gary M. Sclar, Associate Director.

Similar Private Companies By Industry

Company Name Region
Bravo Health Pennsylvania, Inc. United States
Southern New Hampshire Medical Center United States
Angels of the Valley Hospice Care, LLC United States
IAC Holdings, Inc. United States
Massachusetts Vision Service Plan, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Dana-Farber Cancer Institute, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at